Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Arena Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 10.39M 16.61M 12.72M 27.59M 81.39M
Cost of Goods Sold (COGS) incl. D&A 21.06M 19.97M 19.22M 13.42M 10.28M
COGS excluding D&A 6.54M 7.41M 8.1M 3.67M 2.08M
Depreciation & Amortization Expense 14.53M 12.55M 11.12M 9.75M 8.2M
Depreciation 11.02M 10.39M 10.13M 9.06M 7.73M
Amortization of Intangibles 3.51M 2.16M 997,000 691,000 469,000
Gross Income (10.68M) (3.35M) (6.51M) 14.17M 71.11M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 124.39M 93M 72.83M 71.28M 94.05M
Research & Development 110.16M 75.46M 58.71M 54.11M 66.47M
Other SG&A 14.23M 17.54M 14.12M 17.17M 27.58M
Other Operating Expense 0 0 0 0 0
Unusual Expense 385,000 7.98M 13.93M 19.76M (10.15M)
EBIT after Unusual Expense (385,000) (7.98M) (13.93M) (19.76M) 10.15M
Non Operating Income/Expense 273,000 1.02M (1.77M) 400,000 352,000
Non-Operating Interest Income 689,000 469,000 117,000 119,000 89,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 18.72M 21.68M 14.31M 9.12M 7.09M
Gross Interest Expense 18.72M 21.68M 14.31M 9.12M 7.09M
Interest Capitalized 0 0 0 0 0
Pretax Income (153.2M) (124.53M) (109.22M) (85.48M) (19.44M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (153.2M) (124.53M) (109.22M) (85.48M) (19.44M)
Minority Interest Expense 0 0 0 0 0
Net Income (153.2M) (124.53M) (109.22M) (85.48M) (19.44M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (153.2M) (124.53M) (109.22M) (85.48M) (19.44M)
Preferred Dividends 0 0 2.26M 2.82M 0
Net Income Available to Common (153.2M) (124.53M) (111.48M) (88.3M) (19.44M)
EPS (Basic) (1.82) (1.14) (0.80) (0.45) (0.09)
Basic Shares Outstanding 84.34M 109.57M 139.17M 196.52M 218.1M
EPS (Diluted) (1.82) (1.14) (0.80) (0.45) (0.09)
Diluted Shares Outstanding 84.34M 109.57M 139.17M 196.52M 218.1M
EBITDA (120.54M) (83.8M) (68.21M) (47.37M) (14.73M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.